Armin Giese

1995–2025 年に発表

103
論文数
19,554
被引用数
75
h 指数
100
i10 指数

被引用数

Armin Giese の年別被引用数1922 年: 被引用 3 件1980 年: 被引用 1 件1996 年: 被引用 2 件1997 年: 被引用 4 件1998 年: 被引用 22 件1999 年: 被引用 38 件2000 年: 被引用 50 件2001 年: 被引用 79 件2002 年: 被引用 74 件2003 年: 被引用 66 件2004 年: 被引用 91 件2005 年: 被引用 88 件2006 年: 被引用 95 件2007 年: 被引用 72 件2008 年: 被引用 83 件2009 年: 被引用 112 件2010 年: 被引用 142 件2011 年: 被引用 145 件2012 年: 被引用 159 件2013 年: 被引用 111 件2014 年: 被引用 114 件2015 年: 被引用 146 件2016 年: 被引用 188 件2017 年: 被引用 220 件2018 年: 被引用 190 件2019 年: 被引用 723 件2020 年: 被引用 765 件2021 年: 被引用 769 件2022 年: 被引用 641 件2023 年: 被引用 509 件2024 年: 被引用 806 件2025 年: 被引用 393 件2026 年: 被引用 5 件1923〜1979 年は被引用が無いため表示していません1981〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,925 件、この内訳の 20.9%ドイツ: 引用元論文 916 件、この内訳の 9.9%イギリス: 引用元論文 847 件、この内訳の 9.2%イタリア: 引用元論文 631 件、この内訳の 6.9%中国: 引用元論文 523 件、この内訳の 5.7%フランス: 引用元論文 362 件、この内訳の 3.9%カナダ: 引用元論文 344 件、この内訳の 3.7%スペイン: 引用元論文 321 件、この内訳の 3.5%スウェーデン: 引用元論文 265 件、この内訳の 2.9%日本: 引用元論文 262 件、この内訳の 2.8%オーストラリア: 引用元論文 240 件、この内訳の 2.6%オランダ: 引用元論文 230 件、この内訳の 2.5%
0%20.9%その他 25.5%

分野

  • Medicine53.1%
  • Biochemistry, Genetics and Molecular Biology33.8%
  • Neuroscience7%
  • Engineering1.2%
  • Nursing1.1%
  • Mathematics0.9%
  • その他2.9%

トピック

  • Parkinson's Disease Mechanisms and Treatments11%
  • Alzheimer's disease research and treatments8.3%
  • Prion Diseases and Protein Misfolding6.1%
  • Neurological diseases and metabolism4.4%
  • Neurological disorders and treatments4.3%
  • Trace Elements in Health2.5%
  • その他63.4%

共著者

全論文

検索で開く
  1. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Kassubek, Florian Krismer, Johannes Levin, Stefan Lorenzl, Huw R. Morris, Peter J. Nestor, Wolfgang H. Oertel, Werner Poewe, Gil D. Rabinovici, James B. Rowe, Gerard D. Schellenberg, Klaus Seppi, Thilo van Eimeren, Gregor K. Wenning, Adam L. Boxer, Lawrence I. Golbe, Irene Litvan, for the Movement Disorder Society–endorsed PSP Study Group - Movement Disorders 2017 被引用: 2,332

  2. Distribution patterns of tau pathology in progressive supranuclear palsy

    著者: , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2020 被引用: 471

  3. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Griesinger, Armin Giese - Acta Neuropathologica 2013 被引用: 456

  4. Tau deposition patterns are associated with functional connectivity in primary tauopathies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jost J. Rumpf, Matthias L. Schroeter, Joseph Claßen, Victor L. Villemagne, John Seibyl, Andrew Stephens, Edward B. Lee, David G. Coughlin, Armin Giese, Murray Grossman, Corey T. McMillan, Ellen Gelpí, Laura Molina‐Porcel, Yaroslau Compta, John C. van Swieten, Laura Donker Laat, Claire Troakes, Safa Al‐Sarraj, John Robinson, Sharon X. Xie, David J. Irwin, Sigrun Roeber, Jochen Herms, Mikael Simons, Peter Bartenstein, Virginia M. Lee, John Q. Trojanowski, Johannes Levin, Günter U. Höglinger, Michael Ewers - Nature Communications 2022 被引用: 108

  5. Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding

    著者: , , , , , , , , - Journal of Neuroscience 2007 被引用: 798

  6. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John C. van Swieten, Alex Rajput, Leslie W. Ferguson, Mark Cookson, J. Raphael Gibbs, Cornelis Blauwendraat, Jinhui Ding, Ruth Chia, Bryan J. Traynor, Alexander Pantelyat, Coralie Viollet, Bryan J. Traynor, Olga Pletniková, Juan C. Troncoso, Liana S. Rosenthal, Adam L. Boxer, Gesine Respondek, Thomas Arzberger, Sigrun Roeber, Armin Giese, David J. Burn, Nicola Pavese, Alexander Gerhard, Christopher Kobylecki, P. Nigel Leigh, Alistair Church, Michele T.M. Hu - The Lancet Neurology 2020 被引用: 120

  7. Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial

    著者: , , , , , , , , , , , , , , , , - EBioMedicine 2022 被引用: 85

  8. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

    著者: , , , , , , , , , , , , , , , , , , - Movement Disorders 2014 被引用: 379

  9. Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

    著者: , , , - Journal of Clinical Oncology 2003 被引用: 1,206

  10. The Differential Diagnosis and Treatment of Atypical Parkinsonism

    著者: , , , , - Deutsches Ärzteblatt international 2016 被引用: 212

  11. Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes

    著者: , , , , , , , , , , , - ACS Chemical Neuroscience 2019 被引用: 109

  12. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex

    著者: , , , , , , , , , , , , , , , , - Epigenetics & Chromatin 2018 被引用: 256

  13. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Huw R. Morris, Jennifer L. Whitwell, Yaroslau Compta, Jean‐Christophe Corvol, Anthony E. Lang, James B. Rowe, Günter U. Höglinger, for the Movement Disorder Society‐endorsed PSP Study Group - Movement Disorders 2019 被引用: 142

  14. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model

    著者: , , , , , , , , , , , , - Acta Neuropathologica 2019 被引用: 126

  15. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity

    著者: , , , , , , , , , , - Neuro-Oncology 2012 被引用: 302

  16. [11C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates

    著者: , , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2020 被引用: 93

  17. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects

    著者: , , , , , , , , , , , , , , , , , - Annals of Neurology 1999 被引用: 1,449

  18. Quantifying prion disease penetrance using large population control cohorts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús de Pedro‐Cuesta, Stéphane Haı̈k, Jean Laplanche, Élodie Bouaziz-Amar, J.-P. Brandel, Sabina Capellari, Piero Parchi, Anna Poleggi, Anna Ladogana, Anne O’Donnell‐Luria, Konrad J. Karczewski, Jamie L. Marshall, Michael Boehnke, Markku Laakso, Karen L. Mohlke, Anna K. Kähler, Kimberly Chambert, Steven A. McCarroll, Patrick F. Sullivan, Christina M. Hultman, Shaun Purcell, Pamela Sklar, Sven J. van der Lee, Annemieke J.M. Rozemüller, Casper Jansen, Albert Hofman, Robert Kraaij, Jeroen van Rooij, M. Arfan Ikram, André G. Uitterlinden, Cornelia M. van Duijn, Mark J. Daly, Daniel G. MacArthur - Science Translational Medicine 2016 被引用: 469

  19. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2017 被引用: 129

  20. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marco Düring, Jens Ebentheuer, Christopher Fricke, Alexander L. Gerbes, Stefan Jun Groiss, Doreen Gruber, Christian J. Hartmann, Thomas Kirchner, Daniel Kroneberg, Martin Kunz, Stefan Lorenzl, Alexia Moldovan, Anna H. Noda, Heidi Pape, Gesine Respondek, Eva Schäffer, Martina Schneider, Alfons Schnitzler, Walter Schulz‐Schaeffer, Johannes Schwarz, Cornelia Skowronek, Alexander Storch, Vera Tadić, Dávid Vadász, Benno F. Zimmermann - The Lancet Neurology 2019 被引用: 126

  21. Copathology in Progressive Supranuclear Palsy: Does It Matter?

    著者: , , , , , , , , , , , , - Movement Disorders 2020 被引用: 88

  22. Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1

    著者: , , , , , , , , , , , , - The EMBO Journal 2010 被引用: 477

  23. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Lorenzl, Huw R. Morris, Peter J. Nestor, Wolfgang H. Oertel, Gil D. Rabinovici, James B. Rowe, Thilo van Eimeren, Gregor K. Wenning, Adam L. Boxer, Lawrence I. Golbe, Irene Litvan, María Stamelou, Günter U. Höglinger, for the Movement Disorder Society‐Endorsed PSP Study Group - Movement Disorders 2017 被引用: 164

  24. Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy

    著者: , , , , , , , - Movement Disorders 2018 被引用: 115